To apprise Indian pharmaceutical industry about the latest trends and developments concerning regulations in the pharmaceutical industry worldwide, Merck Millipore, the life science division of Merck, organised the third edition of ‘EMPROVE Seminar Series’ in Hyderabad. The theme of the seminar was ‘Risk Mitigation’, which addresses the current challenges faced by the industry.

Attended by over 200 invitees, topics in the seminar ranged from quality by design, Risk-based CMC development solutions presented by Ranjit Barshikar and FDA Inspectional Observations and Warning Letter Citations relating to quality control and assurance by Dr Hemant Mondkar.

The seminar was inaugurated by Tapan Ray, Former President- OPPI. In his inaugural address, he emphasised that it was high time for the industry to “walk the talk” in ethics, values and compliance. Merck Millipore’s panel of speakers addressed various facets of the current issues concerning regulations and shared their expertise with the audience.

This initiative, a service to the industry started by Merck Millipore in 2012, has drawn an ever increasing number of participants, because of its relevance and insights offered by the experts. The idea is to provide a platform for all its stakeholders to enhance their knowledge and keep abreast of latest trends and evolving regulatory agency compliance demands.

Peter Salazar, head, Pharm Chemicals Solutions, Merck Millipore India and pioneer of the EMPROVE Seminar Series remarked, “Today, risk mitigation and sustainability have gained focus and are of high importance to ensure a robust development of the industry. It is imperative that all companies operating in India should take cognisance of this development and prepare themselves adequately by choosing business partners who can address these concerns.